Stocks and Investing
Stocks and Investing
Tue, March 13, 2018
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Mon, March 12, 2018
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
David Nierengarten Downgraded (VYGR) to Hold on, Mar 12th, 2018
David Nierengarten of Wedbush, Downgraded "Voyager Therapeutics, Inc." (VYGR) to Hold on, Mar 12th, 2018.
David has made no other calls on VYGR in the last 4 months.
There are 2 other peers that have a rating on VYGR. Out of the 2 peers that are also analyzing VYGR, 0 agree with David's Rating of Hold.
These are the ratings of the 2 analyists that currently disagree with David
- Jeffrey Hung of "Morgan Stanley" Maintained at Buy with Increased Target to $39 on, Wednesday, February 21st, 2018
- Dane Leone of "BTIG" Initiated at Strong Buy and Held Target at $32 on, Wednesday, December 20th, 2017